Vaccine Manufacturing Capacity

Building vaccine manufacturing capacity requires not only production facilities in various countries but also addressing local health infrastructure and public willingness to vaccinate. The recent experience with Omicron highlighted that having vaccines available is not enough; effective distribution and administration are crucial for global health outcomes. Investing in both high-tech solutions and low-tech infrastructure is essential for future pandemic preparedness.